Allergy Therapeutics PLC | Ownership
Companies that own Allergy Therapeutics PLC
Odey Asset Management LLP
43,747,523
6.88%
0
0.35%
07/18/2018
River & Mercantile Asset Management LLP
35,232,339
5.54%
23,732,339
0.27%
07/25/2018
Invesco Asset Management Ltd.
28,618,373
4.5%
0
0.01%
07/18/2018
BlackRock Investment Management (UK) Ltd.
28,263,964
4.44%
20,000
0%
07/18/2018
Hargreave Hale Ltd.
19,206,000
3.02%
0
0.07%
06/04/2018
Hargreaves Lansdown Stockbrokers Ltd.
9,812,000
1.54%
421,000
0.02%
06/04/2018
Norges Bank Investment Management
7,700,000
1.21%
0
0%
06/04/2018
Miton Asset Management Ltd.
5,385,000
0.85%
0
0.04%
06/04/2018
Legal & General Investment Management Ltd.
3,000,000
0.47%
0
0%
06/04/2018
Charles Schwab Investment Management, Inc.
2,600,000
0.41%
25,000
0%
06/04/2018
| Address |
Dominion Way
Worthing West Sussex BN14 8SA
United Kingdom
|
|
Employees
|
- |
| Website |
http://allergytherapeutics.com |
| Updated |
07/08/2019 |
| Allergy Therapeutics Plc is a pharmaceutical company, which focuses on the treatment and prevention of allergy with aluminum free products. It provides general information for the allergy sufferer and healthcare professionals about the prevention, diagnosis and treatment of the allergic condition with a special focus on allergy vaccination. The company was founded by Keith Iain Carter in 1998 and is headquartered in Worthing, the United Kingdom. |
